Current Trends in Formulation Development and Implications for Drug Delivery

International Pharmaceutical Industry (IPI) is a peer-reviewed journal providing the pharmaceutical and biopharmaceutical industry with coverage on key scientific, technology, regulatory and business topics. The publication has a global audience of professionals involved in outsourcing management for this sector.

The market for parenteral drug device combination products has been evolving over the last 15–20 years, developing innovation both on formulation and device design fronts. This change is driven by a series of factors including: the growth of biologics and biosimilars,  evolving healthcare systems in need of affordable therapeutic options; the rise in self-administration and an increasing focus on patient and user experience.

To read the full article visit p38-39